Evidence map›Paper›PMID 29600443›Full record

ReviewEuropean biophysics journal : EBJ2018

Immuno-receptors: from recognition to signaling and function.

Israel Pecht

Abstract readReview
PubMed Publisher
In one paragraph

Review in European biophysics journal : EBJ, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Pharmaceutics · 2021
    Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Israel PechtDepartment of Immunology, The Weizmann Institute of Science, Rehovot, Israel. israel.pecht@weizmann.ac.il.
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vertebrate adaptive immune response is initiated by specific recognition of antigens. This is carried out by molecules, soluble or cell surface receptors that are members of the Multichain Immune Recognition Receptors (MIRR) group of proteins. The soluble arm of the response is based on antibodies. Kinetic analysis of antibody-antigenic epitope interactions pioneered insights into the complexity underlying the capacity of relatively limited repertoires of antibodies to recognize an essentially unlimited range of epitopes by employing conformational diversity of a given single sequence. The arm responsible for recognition of cellular targets involves a considerably more elaborate process, predominantly of antigen-derived peptides presented bound to molecules encoded by the major histocompatibility complex (MHC). This remarkable cellular recognition process performed by T-cell receptors requires earlier steps of peptide presentation and involves interactions of the receptor sites with the array of its MHC-peptide composite ligand. In both cases, antigen recognition needs to be followed by its coupling, by biochemical cascades, to different specific responses, namely activation of effector functions. The parameters required for coupling to functional responses are still a focus of intense research. In solution, antigen-antibody aggregation is one established activation process. Those required for coupling antigen recognition to cell activation, whether by Fc receptor bound antibodies or by the B-cell antigen receptor, are also still subject to active research efforts. Though activation by immune-receptors requires antigen recognition, considerable differences could exist among the requirements set by distinct cell types. Moreover, antigen binding requiring intercellular interactions introduces additional complexity.

Indexed as

Signal TransductionAnimalsAntibodiesEpitopesHumansProtein BindingReceptors, ImmunologicAntibodiesEpitopesReceptors, ImmunologicAntibodyAntigenic epitopeChemical relaxationKinetics

Identifiers

PMID29600443
OpenAlexW2796423127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.